909 related articles for article (PubMed ID: 28084171)
1. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?
Chan BS; Dawson AH; Buckley NA
Clin Toxicol (Phila); 2017 Feb; 55(2):88-96. PubMed ID: 28084171
[TBL] [Abstract][Full Text] [Related]
2. A Large Case Series of Acute Pediatric Methotrexate Ingestions: Significant Clinical Effects Are Rare.
Hensley MD; Bebarta VS; Borys DJ
Pediatr Emerg Care; 2016 Oct; 32(10):682-684. PubMed ID: 27383404
[TBL] [Abstract][Full Text] [Related]
3. Four-year experience with methotrexate exposures.
LoVecchio F; Katz K; Watts D; Wood I
J Med Toxicol; 2008 Sep; 4(3):149-50. PubMed ID: 18821486
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of toxicity after acute accidental methotrexate ingestions in children under 6 years old: a 16-year multi-center review.
Hays H; Beuhler MC; Spiller HA; Weber J; Mowry JB; Ryan ML; Spiller NE; Webb A
Clin Toxicol (Phila); 2018 Feb; 56(2):120-125. PubMed ID: 28730845
[TBL] [Abstract][Full Text] [Related]
5. Acute bone marrow suppression and gastrointestinal toxicity following acute oral methotrexate overdose.
Isoardi KZ; Harris K; Carmichael KE; Dimeski G; Chan BSH; Page CB
Clin Toxicol (Phila); 2018 Dec; 56(12):1204-1206. PubMed ID: 29973099
[TBL] [Abstract][Full Text] [Related]
6. Acute versus chronic methotrexate poisoning; a cross-sectional study.
Ahmadzadeh A; Zamani N; Hassanian-Moghaddam H; Hadeiy SK; Parhizgar P
BMC Pharmacol Toxicol; 2019 Jul; 20(1):39. PubMed ID: 31269977
[TBL] [Abstract][Full Text] [Related]
7. [Acute methotrexate poisoning: apropos of 16 cases reported to the Paris Poison Control Center and review of the literature].
Maignen F; Guillot B; Pierron E; Julian S; Castot A
Therapie; 1996; 51(5):527-31. PubMed ID: 9138387
[TBL] [Abstract][Full Text] [Related]
8. High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
Dupuis C; Mercier C; Yang C; Monjanel-Mouterde S; Ciccolini J; Fanciullino R; Pourroy B; Deville JL; Duffaud F; Bagarry-Liegey D; Durand A; Iliadis A; Favre R
Anticancer Drugs; 2008 Mar; 19(3):267-73. PubMed ID: 18510172
[TBL] [Abstract][Full Text] [Related]
9. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
Woolf AD; Erdman AR; Nelson LS; Caravati EM; Cobaugh DJ; Booze LL; Wax PM; Manoguerra AS; Scharman EJ; Olson KR; Chyka PA; Christianson G; Troutman WG
Clin Toxicol (Phila); 2007; 45(3):203-33. PubMed ID: 17453872
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia.
Donelli MG; Zucchetti M; Robatto A; Perlangeli V; D'Incalci M; Masera G; Rossi MR
Med Pediatr Oncol; 1995 Mar; 24(3):154-9. PubMed ID: 7838036
[TBL] [Abstract][Full Text] [Related]
12. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
13. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients.
Kawakatsu S; Nikanjam M; Lin M; Le S; Saunders I; Kuo DJ; Capparelli EV
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1339-1348. PubMed ID: 31586225
[TBL] [Abstract][Full Text] [Related]
15. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.
Scharman EJ; Erdman AR; Cobaugh DJ; Olson KR; Woolf AD; Caravati EM; Chyka PA; Booze LL; Manoguerra AS; Nelson LS; Christianson G; Troutman WG;
Clin Toxicol (Phila); 2007; 45(7):737-52. PubMed ID: 18058301
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
Eur J Clin Pharmacol; 1990; 39(4):377-83. PubMed ID: 2076721
[TBL] [Abstract][Full Text] [Related]
18. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
[TBL] [Abstract][Full Text] [Related]
19. High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients.
Holmboe L; Andersen AM; Mørkrid L; Slørdal L; Hall KS
Br J Clin Pharmacol; 2012 Jan; 73(1):106-14. PubMed ID: 21707700
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
Pichlmeier U; Heuer KU
Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
